Biomarkers associated with clinical response to cystic fibrosis pulmonary exacerbation treatment and adjuvant prednisone therapy
Sputum and blood inflammatory markers are associated with early response to IV antibiotics and change with prednisone treatment during PEx.
Authors
- Bradley S. Quon (ORCID: https://orcid.org/0000-0003-1785-3870)
- Michelle Shaw (ORCID: https://orcid.org/0000-0002-0966-6779)
- Félix Ratjen (ORCID: https://orcid.org/0000-0003-4057-6592)
- Hartmut Grasemann (ORCID: https://orcid.org/0000-0003-0331-9642)
- Valerie Waters (ORCID: https://orcid.org/0000-0003-1566-6510)
- Jyoti Matta
Institutions
- University of British Columbia Hospital (CA)
- Hospital for Sick Children (CA)
- St. Paul's Hospital (CA)
- SickKids Foundation (CA)
- St. Paul's Hospital (CA)
Publication Details
- Journal
- Journal of Cystic Fibrosis
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.jcf.2025.08.018
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Cystic Fibrosis Foundation
- Cystic Fibrosis Canada